Analyzing the Role of Checkpoint Inhibitors for the Treatment of Melanoma
YOUR LINK HERE:
http://youtube.com/watch?v=dZmKdXXfqFo
Michael R. Harrison, MD, assistant professor of medicine, Duke Cancer Institute, discusses the possibility of nivolumab (Opdivo) plus ipilimumab (Yervoy) bec...
cancer, oncology
#############################
